MCL1 and neoplasm: Moxifloxacin (another quinolone) can contribute to S-phase arrest and the induction of apoptosis by cisplatin in pancreatic cancer through ERK activation [48], inhibit tumor growth or promote apoptosis in breast cancer by interacting with the Mcl-1 and MITF proteins [49].